Two Cases of 6-Pyruvoyl Tetrahydropterin Synthase Deficiency: Case Report and Literature Review
Lucia Maria Sur,
Monica Alina Mager,
Alexandru-Cristian Bolunduţ,
Adrian-Pavel Trifa,
Dana Teodora Anton-Păduraru
Affiliations
Lucia Maria Sur
Faculty of General Medicine, University of Medicine and Pharmacy Iuliu Haţieganu Cluj-Napoca, 400015 Cluj-Napoca, Romania
Monica Alina Mager
Faculty of General Medicine, University of Medicine and Pharmacy Iuliu Haţieganu Cluj-Napoca, 400015 Cluj-Napoca, Romania
Alexandru-Cristian Bolunduţ
Faculty of General Medicine, University of Medicine and Pharmacy Iuliu Haţieganu Cluj-Napoca, 400015 Cluj-Napoca, Romania
Adrian-Pavel Trifa
Faculty of Medicine, Medical Genetics, University of Medicine and Pharmacy Victor Babes Timisoara, 400349 Cluj-Napoca, Romania
Dana Teodora Anton-Păduraru
Faculty of Medicine, Mother and Child Discipline, Department of Pediatrics, University of Medicine and Pharmacy Grigore T. Popa Iasi, 700115 Iasi, Romania
6-pyruvoyl tetrahydropterin synthase deficiency (PTPSD) is a rare neurometabolic disease that can be diagnosed in newborn screening (NBS) and is part of the family of tetrahydrobiopterin deficiency disorders (BH4Ds). It is essential to diagnose and treat this disease early to prevent permanent neurological damage secondary to this neurotransmitter disorder. We present the first two cases of PTPSD in Romania that were genetically confirmed and treated late. Improving the diagnosis and monitoring procedures in Romania with correct metabolic management will prevent severe neurological impairment from PTPSD or other BH4Ds.